Search | Page 35 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Alemtuzumab

    ... on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes are derived. After treatment with ...

    Drug last updated 03/26/2016 - 8:15pm.

  2. What are the treatments for MDS?

    ... MDS treatment is designed to increase the number of healthy cells in your blood (blood count). When your blood counts go up you are less ... by using drugs that kill abnormal cells. Bone marrow/stem cell transplantation (BMT/SCT): A procedure that replaces your unhealthy ...

    FAQ last updated 03/15/2016 - 11:31pm.

  3. Therapies

    ... can cause your bone marrow to make more red blood cells. This can improve anemia . Androgens are sometimes used to treat ... from attacking your bone marrow, allowing bone marrow stem cells to grow, which raises blood counts. ...

    Page last updated 03/18/2016 - 11:26am.

  4. New therapeutics for myelodysplastic syndromes

    ... MDS is characterized by impaired bone marrow stem cell function, resulting in low blood counts, increased rates of infection ... well as to imbalances among the surrounding, non-cancerous cells (the “MDS microenvironment”).  In this model, progression of an ...

    Research Review last updated 05/02/2016 - 9:28am.

  5. Clinical Trials Report for April 2014

    ... treated with drugs that suppress the immune system or with stem cell transplant. People with SAA who receive these treatments are more ... Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells ...

    Page last updated 04/18/2014 - 3:36pm.

  6. About Bone Marrow Failure

    ... bone marrow .  It is the "factory" that makes blood cells.  Bone marrow contains special cells called stem cells . These blood-forming stem cells grow and mature into the three ...

    Page last updated 07/01/2013 - 4:51pm.

  7. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

    ... understood, but incomplete elimination of auto-reactive T cells and insufficient stem cell reserve are both possible. Furthermore, 10-15% of SAA patients ...

    Clinical Trial last updated 04/25/2016 - 2:47pm.

  8. Policymakers Act on Rare Disease Community’s Behalf

    ... 16, Congress finalized the reauthorization of a bill on stem cells sponsored by U.S. Rep. Chris Smith (R-NJ), who also introduced the ...

    Page last updated 01/08/2016 - 2:39pm.

  9. 2014 Bone Marrow Failure Disease Symposia - Penn State College of Medicine

    ... with Umbilical Cord Blood and Haploidentical Stem Cells : A new and effective Treatment option for patients with ... Witold B. Rybka, MD, Professor and Director, Stem Cell Transplant Program Penn State Hershey Cancer Institute, ...

    Page last updated 10/29/2014 - 3:39pm.

  10. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that ... pre-cryopreservation total nucleated cell dose of > 3 x 107 cells/kg, or double unit grafts, each cord blood unit delivering at least ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.